Search Results - "FURTH, Christian"

Refine Results
  1. 1

    68Ga-PSMA-PET/CT-based radiosurgery and stereotactic body radiotherapy for oligometastatic prostate cancer by Kalinauskaite, Goda, Senger, Carolin, Kluge, Anne, Furth, Christian, Kufeld, Markus, Tinhofer, Ingeborg, Budach, Volker, Beck, Marcus, Hochreiter, Alexandra, Grün, Arne, Stromberger, Carmen

    Published in PloS one (21-10-2020)
    “…Androgen deprivation therapy (ADT) remains the standard therapy for patients with oligometastatic prostate cancer (OMPC). Prostate-specific membrane antigen…”
    Get full text
    Journal Article
  2. 2

    Positron Emission Tomography for Staging of Pediatric Sarcoma Patients: Results of a Prospective Multicenter Trial by VOLKER, Thomas, DENECKE, Timm, HENZE, Günter, AMTHAUER, Holger, STEFFEN, Ingo, MISCH, Daniel, SCHÖNBERGER, Stefan, PLOTKIN, Michail, RUF, Juri, FURTH, Christian, STÖVER, Brigitte, HAUTZEL, Hubertus

    Published in Journal of clinical oncology (01-12-2007)
    “…The objective of this study was to evaluate the impact of positron emission tomography (PET) using fluorine-18-fluorodeoxyglucose (FDG) for initial staging and…”
    Get full text
    Journal Article
  3. 3

    Pretherapeutic FDG-PET total metabolic tumor volume predicts response to induction therapy in pediatric Hodgkin's lymphoma by Rogasch, Julian M M, Hundsdoerfer, Patrick, Hofheinz, Frank, Wedel, Florian, Schatka, Imke, Amthauer, Holger, Furth, Christian

    Published in BMC cancer (03-05-2018)
    “…Standardized treatment in pediatric patients with Hodgkin's lymphoma (HL) follows risk stratification by tumor stage, erythrocyte sedimentation rate and tumor…”
    Get full text
    Journal Article
  4. 4

    Reevaluating the relevance of 18F-FDG PET findings for diagnosis of neurosarcoidosis: a case series by Chen, Jessy, Metzger, Giulia, Furth, Christian, Bohner, Georg, Siffrin, Volker

    Published in Neurological research and practice (25-01-2024)
    “…Abstract Objective The diagnosis of neurosarcoidosis (NS) remains challenging due to the difficulty to obtain central nervous system (CNS) biopsies. Various…”
    Get full text
    Journal Article
  5. 5

    Comparison of diagnostic value of 68 Ga-DOTATOC PET/MRI and standalone MRI for the detection of intracranial meningiomas by Einhellig, Heike C., Siebert, Eberhard, Bauknecht, Hans-C., Tietze, Anna, Graef, Josefine, Furth, Christian, Schulze, Daniel, Miszczuk, Milena, Bohner, Georg, Schatka, Imke, Makowski, Marcus R.

    Published in Scientific reports (27-04-2021)
    “…To evaluate the diagnostic performance of magnetic resonance imaging (MRI) alone in comparison to positron emission tomography/ magnetic resonance imaging…”
    Get full text
    Journal Article
  6. 6

    Reconstructed spatial resolution and contrast recovery with Bayesian penalized likelihood reconstruction (Q.Clear) for FDG-PET compared to time-of-flight (TOF) with point spread function (PSF) by Rogasch, Julian M., Suleiman, Said, Hofheinz, Frank, Bluemel, Stephanie, Lukas, Mathias, Amthauer, Holger, Furth, Christian

    Published in EJNMMI physics (10-01-2020)
    “…Background Bayesian penalized likelihood reconstruction for PET (e.g., GE Q.Clear) aims at improving convergence of lesion activity while ensuring sufficient…”
    Get full text
    Journal Article
  7. 7

    CT radiomics to predict Deauville score 4 positive and negative Hodgkin lymphoma manifestations by Jensen, Laura J., Rogasch, Julian M. M., Kim, Damon, Rießelmann, Juliana, Furth, Christian, Amthauer, Holger, Hamm, Bernd, Steffen, Ingo G., Elgeti, Thomas, Nagel, Sebastian N.

    Published in Scientific reports (21-11-2022)
    “…18F-FDG-PET/CT is standard to assess response in Hodgkin lymphoma by quantifying metabolic activity with the Deauville score. PET/CT, however, is…”
    Get full text
    Journal Article
  8. 8

    Correlation Between Quantitative PSMA PET Parameters and Clinical Risk Factors in Non-Metastatic Primary Prostate Cancer Patients by Zschaeck, Sebastian, Andela, Stephanie Bela, Amthauer, Holger, Furth, Christian, Rogasch, Julian M, Beck, Marcus, Hofheinz, Frank, Huang, Kai

    Published in Frontiers in oncology (22-04-2022)
    “…PSMA PET is frequently used for staging of prostate cancer patients. Furthermore, there is increasing interest to use PET information for personalized local…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    [68Ga]Ga-PSMA PET/MRI, histological PSMA expression and preliminary experience with [177Lu]Lu-PSMA therapy in relapsing high-grade glioma by Truckenmueller, Peter, Graef, Josefine, Scheel, Michael, Vajkoczy, Peter, Capper, David, Kaul, David, Furth, Christian, Amthauer, Holger, Brenner, Winfried, Onken, Julia Sophie

    Published in Frontiers in oncology (02-09-2022)
    “…Purpose High-grade gliomas (HGG) are still associated with a dismal prognosis. Prostate specific membrane antigen (PSMA) is discussed as a theranostic target…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Pindborg Tumor-An Uncommon Odontogenic Tumor Detected by 68Ga-DOTATOC by Herden, Anna, Sabtan, Deema, Warnecke, Katja, Doll, Christian, Furth, Christian

    Published in Diagnostics (Basel) (02-02-2022)
    “…A 62-year-old-woman with a suspected Tumor-induced-osteomalacia (TIO), a rare neoplastic syndrome that results in renal phosphate wasting with…”
    Get full text
    Journal Article
  14. 14

    Optimization of SPECT-CT Hybrid Imaging Using Iterative Image Reconstruction for Low-Dose CT: A Phantom Study by Grosser, Oliver S, Kupitz, Dennis, Ruf, Juri, Czuczwara, Damian, Steffen, Ingo G, Furth, Christian, Thormann, Markus, Loewenthal, David, Ricke, Jens, Amthauer, Holger

    Published in PloS one (21-09-2015)
    “…Hybrid imaging combines nuclear medicine imaging such as single photon emission computed tomography (SPECT) or positron emission tomography (PET) with computed…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Asphericity of Somatostatin Receptor Expression in Neuroendocrine Tumors: An Innovative Predictor of Outcome in Everolimus Treatment? by Wetz, Christoph, Rogasch, Julian, Genseke, Philipp, Schatka, Imke, Furth, Christian, Kreissl, Michael, Jann, Henning, Venerito, Marino, Amthauer, Holger

    Published in Diagnostics (Basel) (22-09-2020)
    “…Background: in patients with gastroenteropancreatic neuroendocrine tumors (GEP-NET), the mTOR inhibitor everolimus is associated with significant improvement…”
    Get full text
    Journal Article
  17. 17

    Performance of Deauville Criteria in [18F] FDG-PET/CT Diagnostics of Giant Cell Arteritis by Siefert, Jeffrey, Kaufmann, Jonas, Thiele, Felix, Walter-Rittel, Thula, Rogasch, Julian, Biesen, Robert, Burmester, Gerd R, Amthauer, Holger, Schneider, Udo, Furth, Christian

    Published in Diagnostics (Basel) (01-01-2023)
    “…In this retrospective study, PET/CT data from 59 patients with suspected giant cell arteritis (GCA) were reviewed using the Deauville criteria to determine an…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Asphericity of tumor FDG uptake in non-small cell lung cancer: reproducibility and implications for harmonization in multicenter studies by Rogasch, Julian M. M., Furth, Christian, Bluemel, Stephanie, Radojewski, Piotr, Amthauer, Holger, Hofheinz, Frank

    Published in EJNMMI research (02-11-2020)
    “…Background Asphericity (ASP) of the primary tumor’s metabolic tumor volume (MTV) in FDG-PET/CT is independently predictive for survival in patients with…”
    Get full text
    Journal Article
  20. 20